نتائج البحث - "Michael F. Crutchlow"

1

دورية أكاديمية

Dose distribution and up‐titration patterns of metformin monotherapy in patients with type 2 diabetes

المؤلفون: Kristy Iglay, Baanie Sawhney, Alex Z. Fu, Gail Fernandes, Michael F. Crutchlow, Swapnil Rajpathak, Kamlesh Khunti

المصدر: Endocrinology, Diabetes & Metabolism, Vol 3, Iss 1, Pp n/a-n/a (2020)

مصطلحات موضوعية: metformin/administration and dosage, retrospective studies, treatment patterns, type 2 diabetes mellitus, United Kingdom, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2398-9238Test

الوصول الحر: https://doaj.org/article/1cdb737209c5481e961ec724982d6f63Test

View record in DOAJ

النص الكامل

2

دورية أكاديمية

Dose distribution and up-titration patterns of metformin monotherapy in patients with type 2 diabetes.

المؤلفون: Kristy Iglay, Baanie Sawhney, Alex Z Fu, Gail Fernandes, Michael F Crutchlow, Swapnil Rajpathak, Kamlesh Khunti

مصطلحات موضوعية: Uncategorized, United Kingdom, metformin/administration and dosage, retrospective studies, treatment patterns, type 2 diabetes mellitus

العلاقة: 2381/11808636.v1; https://figshare.com/articles/journal_contribution/Dose_distribution_and_up-titration_patterns_of_metformin_monotherapy_in_patients_with_type_2_diabetes_/11808636Test

الإتاحة: https://figshare.com/articles/journal_contribution/Dose_distribution_and_up-titration_patterns_of_metformin_monotherapy_in_patients_with_type_2_diabetes_/11808636Test

View record in BASE

3

Dose distribution and up‐titration patterns of metformin monotherapy in patients with type 2 diabetes

المؤلفون: Baanie Sawhney, Gail Fernandes, Kristy Iglay, Michael F. Crutchlow, Alex Z. Fu, Kamlesh Khunti, Swapnil Rajpathak

المصدر: Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism, Vol 3, Iss 1, Pp n/a-n/a (2020)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae8705ce1e9e651c651fcfe69763995fTest
http://europepmc.org/articles/PMC6947691Test

4

Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial

المؤلفون: Raymond L. H. Lam, Julio Rosenstock, Wendy L. Carofano, Roy Eldor, Gregory T. Golm, Philip Home, Baptist Gallwitz, Michael C. Marcos, Priscilla Hollander, Michael F. Crutchlow

المصدر: Diabetes, Obesity and Metabolism. 20:2220-2228

مصطلحات موضوعية: Adult, Blood Glucose, Male, medicine.medical_specialty, Insulin Antibodies, Endocrinology, Diabetes and Metabolism, Insulin Glargine, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Least-Squares Analysis, Adverse effect, Glycated Hemoglobin, Type 1 diabetes, Dosing algorithm, business.industry, Insulin glargine, nutritional and metabolic diseases, Middle Aged, medicine.disease, Hypoglycemia, Clinical trial, Diabetes Mellitus, Type 1, Treatment Outcome, Basal (medicine), Tolerability, Female, lipids (amino acids, peptides, and proteins), Open label, business, Algorithms, hormones, hormone substitutes, and hormone antagonists, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f58ff53d3128cdeebf56d91c4bad422cTest
https://doi.org/10.1111/dom.13354Test

5

Single‐dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK ‐1293 insulin glargine and originator insulin glargine ( L antus) in subjects with type 1 diabetes and healthy subjects

المؤلفون: Michael F. Crutchlow, Linda Morrow, Michael C. Marcos, Kate Mostoller, Chantal Mahon, April M. Barbour, Elaine Watkins, John Palcza, Yang Xu, Marcus Hompesch

المصدر: Diabetes, Obesity and Metabolism. 20:400-408

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e3b722cbaad1892b2878a7e1008ea020Test
https://doi.org/10.1111/dom.13084Test

6

1149-P: A1C Goal Attainment after Metformin (MET) Uptitration With and Without Sitagliptin (SITA): Impact of Baseline and Target A1C

المؤلفون: Raymond L. H. Lam, Edward A. O'Neill, Keith D. Kaufman, Samuel S. Engel, J. Lin, Michael F. Crutchlow

المصدر: Diabetes. 68

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, Metformin, Goal attainment, Tolerability, Shareholder, Spouse, Sitagliptin, Post-hoc analysis, Internal Medicine, medicine, Physical therapy, business, Glycemic, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::76d4316ee7cb30f25cc14619a7cbfadbTest
https://doi.org/10.2337/db19-1149-pTest

7

Double-blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT-M study

المؤلفون: Raymond L. H. Lam, Keith D. Kaufman, Hideo Makimura, Catherine Ntabadde, Samuel S. Engel, Zachary Zimmer, Guillermo Amorin, Carol Iredale, Edward A. O'Neill, Juan P. Frias, Michael F. Crutchlow

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Blood Glucose, Male, Time Factors, endocrine system diseases, Endocrinology, Diabetes and Metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, law.invention, 0302 clinical medicine, Endocrinology, Randomized controlled trial, law, Medicine, education.field_of_study, Middle Aged, Metformin, Treatment Outcome, Tolerability, Sitagliptin, Drug Therapy, Combination, Female, Original Article, type 2 diabetes, medicine.drug, Adult, medicine.medical_specialty, Population, Urology, 030209 endocrinology & metabolism, Placebo, Drug Administration Schedule, sitagliptin, 03 medical and health sciences, Double-Blind Method, Internal Medicine, Humans, education, Adverse effect, Aged, Glycated Hemoglobin, Dose-Response Relationship, Drug, business.industry, Sitagliptin Phosphate, nutritional and metabolic diseases, Original Articles, medicine.disease, randomised trial, Diabetes Mellitus, Type 2, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::190aca559cbaf737640d8718b589e92fTest
https://pubmed.ncbi.nlm.nih.gov/30609212Test

8

Clinical Evaluation of MK-2640: An Insulin Analog With Glucose-Responsive Properties

المؤلفون: Bob Thornton, David E. Kelley, Linda Morrow, S. Aubrey Stoch, Sandra A.G. Visser, Alexander W. Krug, Harold S. Bernstein, Niels C. Kaarsholm, Marian Iwamoto, Kuenhi Tsai, Michael F. Crutchlow, Craig Fancourt, Bhargava Kandala

المصدر: Clinical pharmacology and therapeutics. 105(2)

مصطلحات موضوعية: Adult, Blood Glucose, Male, medicine.medical_specialty, Adolescent, medicine.medical_treatment, Insulin analog, 030226 pharmacology & pharmacy, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Pharmacokinetics, Double-Blind Method, Antigens, CD, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Insulin, Pharmacology (medical), Pharmacology, Type 1 diabetes, Cross-Over Studies, biology, Dose-Response Relationship, Drug, business.industry, Glucose clamp technique, Middle Aged, medicine.disease, Crossover study, Receptor, Insulin, Insulin receptor, Endocrinology, Diabetes Mellitus, Type 1, 030220 oncology & carcinogenesis, biology.protein, Glucose Clamp Technique, Administration, Intravenous, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c30f7b7b3d056fa379e71ace2ead94e3Test
https://pubmed.ncbi.nlm.nih.gov/30125349Test

9

Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial

المؤلفون: Gregory T. Golm, Roy Eldor, Wendy L. Carofano, Priscilla Hollander, Raymond L. H. Lam, Baptist Gallwitz, Julio Rosenstock, Michael F. Crutchlow, Marc Rendell, Philip Home, Michael C. Marcos

المصدر: Diabetes, obesitymetabolism. 20(9)

مصطلحات موضوعية: Blood Glucose, Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Insulin Antibodies, Insulin Glargine, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, cardiovascular diseases, Least-Squares Analysis, Adverse effect, Aged, Glycated Hemoglobin, Insulin glargine, business.industry, Insulin, nutritional and metabolic diseases, Type 2 Diabetes Mellitus, Middle Aged, medicine.disease, Hypoglycemia, Clinical trial, Treatment Outcome, Tolerability, Diabetes Mellitus, Type 2, lipids (amino acids, peptides, and proteins), Female, Open label, business, hormones, hormone substitutes, and hormone antagonists, Algorithms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c96a8b328630c8bc2c369cf6bebca094Test
https://pubmed.ncbi.nlm.nih.gov/29761615Test

10

Calcineurin Signaling Regulates Human Islet β-Cell Survival

المؤلفون: Diva D. De León, Jeffrey C. Raum, Ali Naji, Doris A. Stoffers, Scott A. Soleimanpour, David N. Groff, Jake A. Kushner, Michael F. Crutchlow, Alana M. Ferrari, Matthew M. Rankin, Chengyang Liu

المصدر: Journal of Biological Chemistry. 285:40050-40059

مصطلحات موضوعية: medicine.medical_specialty, Cell Survival, Apoptosis, Biology, Biochemistry, Glucagon-Like Peptide-1 Receptor, Tacrolimus, Rats, Sprague-Dawley, Mice, Phosphatidylinositol 3-Kinases, Cell Line, Tumor, Insulin-Secreting Cells, Internal medicine, Cyclic AMP, Diabetes Mellitus, Receptors, Glucagon, medicine, Animals, Humans, Hypoglycemic Agents, Phosphorylation, Molecular Biology, PI3K/AKT/mTOR pathway, Cell Proliferation, NFATC Transcription Factors, Venoms, Calcineurin, Molecular Bases of Disease, NFAT, Organ Transplantation, Cell Biology, Rats, Insulin receptor, Endocrinology, Gene Expression Regulation, Insulin Receptor Substrate Proteins, Cancer research, biology.protein, Exenatide, Signal transduction, Peptides, Proto-Oncogene Proteins c-akt, Immunosuppressive Agents, Signal Transduction

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a6916339c8c633a10eb54dc93e857bTest
https://doi.org/10.1074/jbc.m110.154955Test

تنقيح النتائج